To study the safety and efficacy of hypofractionated intensity modulated radiotherapy for patients with intermediate-risk prostate cancer.
Not Applicable
- Conditions
- prostate cancer
- Registration Number
- JPRN-UMIN000003218
- Lead Sponsor
- Department of Radiation Oncology, The Cancer Institute Hospita, the Japanese Fundation for Cancer Reseach
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) Small cell carcinoma 2) Previous or concurrent invasive cancers 3) Previous pelvic irradiation 4) Previous orchiectomy 5) Previous treatment of prostate cancer other than hormonal therapy 6) Cases judged by their physicians to be inappropriate as subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of late adverse effects at three years
- Secondary Outcome Measures
Name Time Method